The Novel Food Event Series
Feed the Next Generation Through Scientific Innovation: Engineering Human & Environmental Health, Wellbeing & Food Security
Since its inception in 2015, the Novel Food Series has emerged as a distinguished platform, spotlighting advancements in scientific innovation and fostering strategic alliances within alternative proteins, agriculture, human nutrition and more. Distinguished by a case study-centric approach, the Novel Food Series places a premium on pioneering methodologies, comprehensive data analysis, and strategic insights, empowering participants to make well-informed decisions in navigating their products to market success. Created by and for Industry experts, the conferences provide exclusive networking opportunities of a niche and premium nature, offering a curated environment to cut through the noise and engage with key stakeholders essential for advancing your organizational mission.
Alternative Proteins & Functional Ingredients
Novel Technologies:
February I San Francisco, CA
Unlock Fermentation's Potential to Commercialize Novel Protein Ingredients & Products
July I Amsterdam, NL
Advance the Science and Infrastructure Required for a Successful Scaled B2B or B2C Alternative Protein
August I Boston, MA
Bringing the Nutritional Value of Formula Towards the Holy Grail of Human Breast Milk
March I Amsterdam, NL
Overcome Scale Up Challenges for Cost Comparable & Quality Products
April I San Fransisco, CA
Engineer Great Tasting Fats & Oils for Plant-Based, Hybrid & Sustainable Food
October I Atlanta, GA
Adopting Innovative Sugar Alternatives to Enhance Product Taste & Nutrition
Growing Capabilities:
November I Chicago, IL
Reduce Downstream Processing Costs, Improve Capex, & Optimize Formulation Across Plant-Based & Fermentation to Deliver Tasty & Functional Ingredients & Products
Next Generation Agriculture
Growing Capabilities:
February I Raleigh, NC
Commercialize Regulatory Approved Gene Edited Agriculture Products
November I San Fransisco
Optimize Your Novel Foods' Downstream Processing for Reduced Cost, Improved Titer, Upmost Quality & Commercial Scalability